LEADER 01253nam1-22003491i-450- 001 990000156410403321 005 20040213113514.0 010 $a88-85423-94-9 035 $a000015641 035 $aFED01000015641 035 $a(Aleph)000015641FED01 035 $a000015641 100 $a20020821d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aM11$eprogettare e installare con la legge 46$f90$fEnte nazionale italiano di unificazione 205 $a4.ed. 210 $aMilano$cEnte Nazionale Italiano di Unificazione$d1999- 215 $av.$cill.$d24 cm 463 \1$1001990000184120403321$12001 $a2.: Antincendio : parte 1. : impianti 463 \1$1001990000184140403321$12001 $a1.: Utilizzazione del gas combustibileparte: P. 1.: impianti 463 \1$1001990000184150503321$12001 $a1.: Utilizzazione del gas combustibile: P. 2.: componenti e materiali 610 0 $aImpianti per gas$aNorme tecniche$aItalia 610 0 $aImpianti per gas$aSicurezza$aLegislazione$aItalia 676 $a696.2 710 02$aEnte nazionale italiano di unificazione$021745 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000156410403321 959 $aFINBC 996 $aM11$9120297 997 $aUNINA LEADER 00840nam0-2200289 --450 001 9910341657603321 005 20191016102438.0 010 $a978-88-6440-089-1 100 $a20191016d2013----kmuy0itay5050 ba 101 1 $aita$ceng 102 $aIT 105 $a 001yy 200 1 $aBreve storia della libertà$fDavid Schmidtz e Jason Brennan$gprefazione di Guido Vitiello 210 $aTorino$cIBL Libri$d2013 215 $a274 p.$d21 cm 225 1 $aMercato, diritto e libertà 676 $a123.5$v21 700 1$aSchmidtz,$bDavid$0141320 701 1$aBrennan,$bJason$0480880 702 1$aVitiello,$bGuido 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910341657603321 952 $aII L 170$b1476/2019$fFSPBC 959 $aFSPBC 996 $aBreve storia della libertà$91563580 997 $aUNINA LEADER 01323nam--2200373---450 001 990001820880203316 005 20220406113505.0 035 $a000182088 035 $aUSA01000182088 035 $a(ALEPH)000182088USA01 035 $a000182088 100 $a20040705d1922----km-y0itay0103----ba 101 0 $afre 102 $aFR 105 $aa|||||||001yy 200 1 $a<> céramique chinoise$fMusée du Louvre$gpar J. J. Marquet de Vasselot et M.-J. Ballot 210 $aParis$cAlbert Morancé$d1922 215 $avolumi$ciil.$d22 cm 225 2 $aDocuments d'art 327 1 $a1. : De l'Epoque des Han à l'Epoque des Ming (206 av. J.C.-1643). - 31 p., 40 carte di tav. sciolte in cartella. -2. : De l'epoque de K'ang-Hi à nos jours (1662-1911), 31 p., 40 carte di tav. sciolte in cartella 410 0$12001$aDocuments d'art 454 1$12001 461 1$1001-------$12001 702 1$aBALLOT,$bMarie Juliette 702 1$aMARQUET DE VASSELOT,$bAlphonse Jean Joseph 710 02$aMusée national du Louvre $0563978 801 0$aIT$bsalbc$gISBD 912 $a990001820880203316 951 $aXI.2.B. 97/1(VII D 317)$b46895 L.M.$cVII D 951 $aXI.2.B. 97/2(VII D 317 bis)$b46896 L.M.$cVII D 959 $aBK 969 $aUMA 996 $aCéramique chinoise$9950636 997 $aUNISA LEADER 05011nam 22005535 450 001 9910847072203321 005 20251113184211.0 010 $a981-9955-75-0 024 7 $a10.1007/978-981-99-5575-6 035 $a(CKB)31240226600041 035 $a(MiAaPQ)EBC31233291 035 $a(Au-PeEL)EBL31233291 035 $a(DE-He213)978-981-99-5575-6 035 $a(EXLCZ)9931240226600041 100 $a20240329d2024 u| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSynbiotics in Human Health: Biology to Drug Delivery /$fedited by Kamal Dua 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (730 pages) 311 08$a981-9955-74-2 320 $aIncludes bibliographical references and index. 327 $aIntroduction to Synbiotics -- Role of Synbiotics on modulation of inflammation -- Role of synbiotics in inflammatory lung diseases -- Role of Synbiotics in Neurodegenerative Diseases -- Role of Synbiotics in Gastrointestinal Disorders -- Role of Synbiotics in Cardiovascular diseases -- ROLE OF SYNBIOTICS IN THROMBOTIC DISORDERS -- Role of Synbiotics in Reproductive disorders -- Role of Synbiotics in Metabolic Disorders -- SYNBIOTICS FOR THE PREVENTION AND TREATMENT OF SKIN DISORDERS -- Cellular and Molecular mechanisms involving synbiotics in various disease state -- Clinical Trial with Synbiotics in Various Disease State -- FUTURE PERSPECTIVE AND SAFETY ISSUES OF SYNBIOTICS IN DIFFERENT DISEASES -- Role of nutraceutical-based synbiotics in the biological homeostasis -- Synergistic welfare of synbiotic nutraceuticals on chronic respiratory diseases -- Synergistic welfare of symbiotic nutraceuticals on gut health -- Synergistic welfare of synbiotic nutraceuticals on neurological function -- SynergisticWelfare of Synbiotic Nutraceuticals on Reproductive Health -- Quality Control and Evaluation of Synbiotics Neutraceutical Product -- Toxicological profile of nutraceutical supplements -- TRANSLATIONAL RESEARCH & CLINICAL ADVANCEMENTS WITH NUTRACEUTICAL SUPPLEMENTS -- Regulatory Aspects and Bottlenecks for Nutraceuticals -- Future prospects and advancement in synbiotics containing Nutraceuticals -- Synbiotics and Drug Delivery: An introduction -- Emerging era of ?biotics?: Prebiotics, probiotics and synbiotics -- Therapeutic potential of synbiotics in management of various disorders -- Synbiotics: Safety assessment and role in the prevention of diseases -- Synbiotics as a nutraceutical adjuvant: neuroprotective and neurorestorative effects -- Synbiotics: Complementary and synergistic approach against different carcinomas -- SYNBIOTICS IN ORAL DRUG DELIVERY -- Applications of synbiotics as cosmeceuticals -- Advanced drug delivery approaches containing synbiotics -- Ideal Synbiotics: Pharmacokinetic, pharmacodynamic and safety assessment -- Regulatory Aspects of Synbiotics-Based Delivery System -- An update on clinical trials on synbiotics. 330 $aThis reference book discusses the role of synbiotics in a wide range of disease states, including cardiovascular, reproductive, metabolic, neurodegenerative, gastrointestinal, thrombotic, skin, and inflammatory disorders. It reviews the functions of probiotics in the diagnosis, prevention, or treatment of various disease states. The book further covers improving the targeting efficiency of synbiotics through advanced drug delivery systems such as nanoparticles, microparticles, liposomes, microemulsion, solid lipid nanoparticles, and nano lipid carriers. The chapter addresses the implications of oral and topical delivery of synbiotics in different diseases and presents the safety assessment of synbiotics and clinical trials associated with synbiotics containing drug delivery systems for the treatment of diseases. The book also explores the synergistic welfare of synbiotics nutraceuticals in various conditions such as chronic respiratory diseases, gut health, and neurological functions and examines the toxicological profile, and regulatory aspects of nutraceutical supplements. As such, this book is a valuable resource for academics, research and industry professionals working in Pharmaceutical Sciences, Food Biotechnology, Immunology, and Health Sciences. 606 $aPharmacology 606 $aMedical care 606 $aDrug delivery systems 606 $aPharmacology 606 $aHealth Care 606 $aDrug Delivery 615 0$aPharmacology. 615 0$aMedical care. 615 0$aDrug delivery systems. 615 14$aPharmacology. 615 24$aHealth Care. 615 24$aDrug Delivery. 676 $a615.6 702 $aDua$b Kamal 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910847072203321 996 $aSynbiotics in Human Health: Biology to Drug Delivery$94464479 997 $aUNINA